CCL13 and depressive disorder: This study endeavors to shed light on the utility of TNF-α and MCP-4 as potential biomarkers for MDD, advancing our understanding of the complex interplay between immune dysregulation and depressive disorders and offering promising insights into improved diagnostic and therapeutic approaches.